Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
Magdalena Rausch(University of Geneva), Patrycja Nowak‐Sliwinska(University of Geneva)
Cited by 20
Related Papers
Consensus guidelines for the use and interpretation of angiogenesis assays
|Angiogenesis|2018|592
Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma
|Scientific Reports|2019|152
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy
|Angiogenesis|2022|51
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment
|Molecular Oncology|2020|29
Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma
|British Journal of Cancer|2020|22